Previous 10 | Next 10 |
2024-01-10 13:15:00 ET Summary Gotham City's recent allegations against Grifols have caused GFRS stock to significantly decline. Our team at Mare will remain waiting for clarifications. We expect the company's stock to be under pressure in the short term and probably not investabl...
2024-01-10 06:30:00 ET Summary Grifols' position in the pharma industry has dropped due to a short-seller report, causing its stock to decline. The report questions the accounting treatment of M&As and consolidation of entities in Grifols' filings. I believe that the alleg...
ATLANTA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Grifols S.A. (“Grifols” or the “Company”) (NASDAQ: GRFS) complied with federal securities laws. On January 9, 2024, Gotham City Research published a report alleging t...
2024-01-09 16:20:04 ET Gainers: WISeKey International ( WKEY ) +14% . MaxCyte ( MXCT ) +8% . Humacyte. ( HUMA ) +8% . Agora ( API ) +6% . Urban Outfitters ( URBN ) +6% . Losers: Grifols ( GRFS ) -9% . Ex...
SAN FRANCISCO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Grifols, S.A. (NASDAQ: GRFS) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/grfs Contact An Attorney Now: GRFS@hbsslaw.com 844-916-...
MONSEY, N.Y., Jan. 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Grifols, S.A. (Nasdaq: GRFS) (“Grifols”) has violated federal securities laws based on allegations in a report published today by Gotham City Research (“Gotham...
BOSTON, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Grifols S.A. ADR (NASDAQ: GRFS) for potential securities law violations. Investors who have lost money in their Grifols S.A. ADR investment should contact the firm to learn more about how they might recover those l...
2024-01-09 08:21:38 ET More on Pre-market losers $ stocks. Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript Cyclacel Pharmaceuticals announces registered direct and private placement offering Financial information for Aclarion, Inc. Seek...
2024-01-09 06:46:54 ET More on Grifols S.A. Grifols Is Building Momentum Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript Grifols gains on plans to sell 20% of Shanghai RAAS stake to Haier Grifols said to be in talks for a partial sale of Shanghai RAAS ...
2023-12-29 12:01:35 ET More on Grifols Grifols Is Building Momentum Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript Grifols said to be in talks for a partial sale of Shanghai RAAS Seeking Alpha’s Quant Rating on Grifols S.A. Historical ea...
News, Short Squeeze, Breakout and More Instantly...
2024-06-12 02:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Grifols 2023 Annual Report on Form 20-F filed with the SEC PR Newswire BARCELONA, Spain , April 19, 2024 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived me...
2024-03-23 01:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...